{"schema_version":"secwatch.filing_event.v1","accession":"0000078003-26-000005","form_type":"8-K","ticker":"PFE","cik":"0000078003","company_name":"PFIZER INC","filed_at":"2026-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.684859+00:00","generated_at":"2026-05-16T05:29:58.772559+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Pfizer reports FY2025 revenue $62.6B, adj. EPS $3.22; reaffirms FY2026 guidance","bullets":["Full-year 2025 revenue $62.6B (-2% operational); non-COVID portfolio +6% operational.","FY2025 reported diluted EPS $1.36; adjusted diluted EPS $3.22 (+4% YoY).","Q4 2025 revenue $17.6B (-1%); Q4 reported LPS ($0.29); adj. diluted EPS $0.66.","Completed Metsera acquisition (~$7B); ViiV stake sale for $1.875B; reaffirms FY2026 revenue guidance $59.5-62.5B, adj. EPS $2.80-3.00."],"urls":{"canonical":"https://secwatch.observer/filing/0000078003-26-000005","json":"https://secwatch.observer/filing/0000078003-26-000005.json","markdown":"https://secwatch.observer/filing/0000078003-26-000005.md","text":"https://secwatch.observer/filing/0000078003-26-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/78003/000007800326000005/0000078003-26-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/78003/000007800326000005/pfe-20260203.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:29:58.772559+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}